Literature DB >> 20573871

Distribution of emm types and genetic characterization of the mgc locus in group G Streptococcus dysgalactiae subsp. equisimilis from a hospital in northern Taiwan.

Sung-Pin Tseng1, Yu-Yin Lin, Jui-Chang Tsai, Po-Ren Hsueh, Hsiao-Jan Chen, Wei-Chun Hung, Lee-Jene Teng.   

Abstract

A total of 274 Streptococcus dysgalactiae subsp. equisimilis isolates was analyzed by emm typing and by determining the organization of their mgrC loci. Three of the most frequent emm types were stG485.0 (45/274, 16.4%), stG6.1 (43/274, 15.7%), and stC839.0 (32/274, 11.7%), in decreasing order. The cpdB-positive mgrC locus appears to be predominant in some emm types.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20573871      PMCID： PMC2916628          DOI： 10.1128/JCM.00444-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  16 in total

1.  Survey of emm-like gene sequences from pharyngeal isolates of group C and group G streptococci collected in Spain.

Authors:  Sebastián Albertí; Cesar García-Rey; María Isabel García-Laorden; Rafael Dal-Ré; Juan García-de-Lomas
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

2.  Clonal relationships between invasive and noninvasive Lancefield group C and G streptococci and emm-specific differences in invasiveness.

Authors:  M D Pinho; J Melo-Cristino; M Ramirez
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

3.  Isolation and sequence analysis of the gene (cpdB) encoding periplasmic 2',3'-cyclic phosphodiesterase.

Authors:  J Liu; D M Burns; I R Beacham
Journal:  J Bacteriol       Date:  1986-03       Impact factor: 3.490

4.  Genetic organisation of the M protein region in human isolates of group C and G streptococci: two types of multigene regulator-like (mgrC) regions.

Authors:  A Geyer; K H Schmidt
Journal:  Mol Gen Genet       Date:  2000-01

5.  Six-month multicenter study on invasive infections due to Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis in Argentina.

Authors:  Horacio A Lopardo; Patricia Vidal; Monica Sparo; Paola Jeric; Daniela Centron; Richard R Facklam; Hugo Paganini; N Gaston Pagniez; Marguerite Lovgren; Bernard Beall
Journal:  J Clin Microbiol       Date:  2005-02       Impact factor: 5.948

6.  Cloning and characterization of the gene encoding periplasmic 2',3'-cyclic phosphodiesterase of Yersinia enterocolitica O:8.

Authors:  K Trülzsch; A Roggenkamp; C Pelludat; A Rakin; C Jacobi; J Heesemann
Journal:  Microbiology       Date:  2001-01       Impact factor: 2.777

7.  Genetic relationships deduced from emm and multilocus sequence typing of invasive Streptococcus dysgalactiae subsp. equisimilis and S. canis recovered from isolates collected in the United States.

Authors:  Yusra Ahmad; Robert E Gertz; Zhongya Li; Varja Sakota; Laura N Broyles; Chris Van Beneden; Richard Facklam; P Lynn Shewmaker; Arthur Reingold; Monica M Farley; Bernard W Beall
Journal:  J Clin Microbiol       Date:  2009-04-22       Impact factor: 5.948

8.  Characterization of group C and G streptococcal strains that cause streptococcal toxic shock syndrome.

Authors:  Shinnosuke Hashikawa; Yoshitsugu Iinuma; Manabu Furushita; Teruko Ohkura; Toshi Nada; Keizo Torii; Tadao Hasegawa; Michio Ohta
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

9.  The role of group C and group G streptococci in acute pharyngitis in children.

Authors:  T Zaoutis; M Attia; R Gross; J Klein
Journal:  Clin Microbiol Infect       Date:  2004-01       Impact factor: 8.067

10.  Group G streptococcal bacteremia in Jerusalem.

Authors:  Ronit Cohen-Poradosu; Joseph Jaffe; David Lavi; Sigal Grisariu-Greenzaid; Ran Nir-Paz; Lea Valinsky; Mary Dan-Goor; Colin Block; Bernard Beall; Allon E Moses
Journal:  Emerg Infect Dis       Date:  2004-08       Impact factor: 6.883
View more
  6 in total

1.  Molecular characterization and antibiotic resistance of group G streptococci in Israel: comparison of invasive, non-invasive and carriage isolates.

Authors:  T Halperin; H Levine; Z Korenman; S Burstein; R Amber; T Sela; L Valinsky
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-21       Impact factor: 3.267

2.  Adult invasive and noninvasive infections due to Streptococcus dysgalactiae subsp. equisimilis in France from 2006 to 2010.

Authors:  Julien Loubinoux; Céline Plainvert; Gislène Collobert; Gérald Touak; Anne Bouvet; Claire Poyart
Journal:  J Clin Microbiol       Date:  2013-05-22       Impact factor: 5.948

3.  Region specific and worldwide distribution of collagen-binding M proteins with PARF motifs among human pathogenic streptococcal isolates.

Authors:  Silvana Reissmann; Christine M Gillen; Marcus Fulde; René Bergmann; Andreas Nerlich; Reena Rajkumari; Kootallur N Brahmadathan; Gursharan S Chhatwal; D Patric Nitsche-Schmitz
Journal:  PLoS One       Date:  2012-01-11       Impact factor: 3.240

4.  Molecular Epidemiological Features and Antibiotic Susceptibility Patterns of Streptococcus dysgalactiae subsp. equisimilis Isolates from Korea and Japan.

Authors:  Sunjoo Kim; Jung Hyun Byun; Hyunwoong Park; Jaehyeon Lee; Hye Soo Lee; Haruno Yoshida; Akiyoshi Shibayama; Tomohiro Fujita; Yuzo Tsuyuki; Takashi Takahashi
Journal:  Ann Lab Med       Date:  2018-05       Impact factor: 3.464

5.  Substrate Specificity of Chimeric Enzymes Formed by Interchange of the Catalytic and Specificity Domains of the 5'-Nucleotidase UshA and the 3'-Nucleotidase CpdB.

Authors:  Alicia Cabezas; Iralis López-Villamizar; María Jesús Costas; José Carlos Cameselle; João Meireles Ribeiro
Journal:  Molecules       Date:  2021-04-16       Impact factor: 4.411

6.  Molecular Dissection of Escherichia coli CpdB: Roles of the N Domain in Catalysis and Phosphate Inhibition, and of the C Domain in Substrate Specificity and Adenosine Inhibition.

Authors:  Iralis López-Villamizar; Alicia Cabezas; Rosa María Pinto; José Canales; João Meireles Ribeiro; Joaquim Rui Rodrigues; María Jesús Costas; José Carlos Cameselle
Journal:  Int J Mol Sci       Date:  2021-02-17       Impact factor: 5.923
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.